Author:
Parodis Ioannis,Lindblom Julius,Cetrez Nursen,Palazzo Leonardo,Ala Henri,Houssiau Frédéric A.,Sjöwall Christopher,Rovin Brad H.
Reference24 articles.
1. B cell therapy in systemic lupus erythematosus: from rationale to clinical practice;Parodis;Front Med (Lausanne),2020
2. Efficacy and safety of Belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial;Navarra;Lancet,2011
3. A phase III, randomized, placebo-controlled study of Belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus;Furie;Arthritis Rheum,2011
4. Safety and efficacy of intravenous Belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial;Brunner;Ann Rheum Dis,2020
5. Two-year, randomized, controlled trial of Belimumab in lupus nephritis;Furie;N Engl J Med,2020
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献